1. Home
  2. NXT vs PEN Comparison

NXT vs PEN Comparison

Compare NXT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nextracker Inc.

NXT

Nextracker Inc.

HOLD

Current Price

$85.70

Market Cap

13.6B

Sector

Technology

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$321.65

Market Cap

12.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXT
PEN
Founded
2013
2004
Country
United States
United States
Employees
N/A
4700
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
12.6B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
NXT
PEN
Price
$85.70
$321.65
Analyst Decision
Buy
Hold
Analyst Count
21
16
Target Price
$115.67
$360.14
AVG Volume (30 Days)
2.5M
257.8K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
10.66
1155.56
EPS
1.07
1.70
Revenue
$3,559,390,000.00
$1,403,665,000.00
Revenue This Year
$19.76
$14.34
Revenue Next Year
$11.96
$13.71
P/E Ratio
$83.72
$188.82
Revenue Growth
20.28
17.50
52 Week Low
$64.33
$221.26
52 Week High
$163.13
$362.41

Technical Indicators

Market Signals
Indicator
NXT
PEN
Relative Strength Index (RSI) 39.20 46.24
Support Level $85.37 $321.38
Resistance Level $94.52 $323.10
Average True Range (ATR) 3.82 1.97
MACD -0.37 -0.69
Stochastic Oscillator 17.71 14.67

Price Performance

Historical Comparison
NXT
PEN

About NXT Nextracker Inc.

Nextpower (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextpower's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextpower has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: